Bulk Pharmaceutical API Sources for AMINOSALICYLATE SODIUM

Bulk Pharmaceutical API Sources for AMINOSALICYLATE SODIUM

Vendor	Vendor Homepage	Vendor Sku	API Url
ChemExper Chemical Directory		HmvL@EAFR[f_FV``H@@
ChemExper Chemical Directory		HcNL`McNCPRVygyVfB@`@@
Sigma-Aldrich		A79604_ALDRICH

Bulk Active Pharmaceutical Ingredient (API) Sources for: AMINOSALICYLATE SODIUM

Last updated: August 6, 2025

Introduction

Aminosalicylate sodium (PAS) is a critical anti-tubercular agent utilized primarily in multi-drug resistant tuberculosis (MDR-TB) treatment regimens. As an active pharmaceutical ingredient (API), its procurement involves navigating a complex global supply chain, with numerous manufacturers specializing in bulk production. The sourcing strategy for aminossalicylate sodium requires rigorous assessment of quality standards, regulatory compliance, and reliability to ensure consistent supply for pharmaceutical formulations.

Overview of Aminosalicylic Acid Sodium API

Aminosalicylic acid sodium, commonly known as PAS sodium, is a derivative of aminosalicylic acid with specific therapeutic roles in managing tuberculosis. The API's chemical integrity, purity, and batch-to-batch consistency are essential, given its use in critical care settings.

Global API Manufacturing Landscape

The global API manufacturing landscape for aminosalicylic acid sodium features several key regions, primarily led by India, China, Europe, and the United States. These regions host established API producers with varying capacities and certifications, such as cGMP compliance, WHO GMP certification, and ISO standards.

1. India

   India remains the dominant source for aminosalicylic acid sodium APIs due to its substantial generic API manufacturing capacity, cost advantages, and manufacturing expertise. Several Indian pharmaceutical companies are registered with regulatory agencies like the Central Drugs Standard Control Organization (CDSCO).

2. China

   Chinese API producers are renowned for high-volume production capabilities, often supplying both domestic and international markets. Chinese manufacturers frequently focus on cost competitiveness, although stringent quality control and regulatory scrutiny are essential for exported APIs.

3. Europe

   European manufacturers tend to adopt rigorous quality standards, including adherence to EMA guidelines. Though limited in number compared to Asian counterparts, European suppliers often serve markets with strict regulatory requirements, emphasizing high purity and batch traceability.

4. United States

   United States-based API manufacturers focus on high-quality production with compliance to FDA regulations. U.S. suppliers typically cater to clients requiring rigorous regulatory assurances, including detailed documentation and stability data.

Major API Suppliers for Aminosalicylic Acid Sodium

Below are some leading API manufacturers and suppliers, segmented by region.

India

• Hetero Labs Limited: A prominent API manufacturer with WHO GMP certification, offering aminosalicylic acid sodium with documented quality control.
• Shilpa Pharmaceutical Ltd.: Known for producing high-purity APIs for anti-tubercular drugs, including PAS sodium.
• Lupin Limited: An established global pharmaceutical player manufacturing APIs compliant with international standards.

China

• North China Pharmaceutical Group Corporation (NCPC): Known for large-scale API production, including aminosalicylic acid derivatives.
• BY-HEALTH Co., Ltd.: Provides APIs with a focus on cost-effective sourcing, with certifications upon request.

Europe

• Sz Farma: Operating in the EU, providing APIs with rigorous quality standards tailored for European markets.
• Recipharm: Offers custom API manufacturing, including aminosalicylic acid sodium, with compliant quality documentation.

United States

• RxCelerate: An API manufacturing and supply company with FDA compliance, offering high-quality aminosalicylic acid sodium APIs.
• Cambridge Commodities: Specializes in sourcing and supplying pharmaceutical raw materials, including APIs, with compliance documentation.

Key Criteria for Selecting API Suppliers

When selecting suppliers for aminosalicylic acid sodium, attention to the following factors is critical:

• Regulatory Compliance: Ensure suppliers have relevant certifications (WHO GMP, EU GMP, FDA) and regulatory track record.
• Quality Control: Comprehensive quality assurance protocols, including extensive batch testing, impurity profiling, and stability data.
• Purity & Specifications: The API should meet compendial standards (e.g., USP, BP, EP) with specified purity levels (typically >99%) and acceptable impurity limits.
• Supply Reliability: Consider supplier capacity, history of timely deliveries, and contingency planning.
• Cost & Lead Times: Balance cost-effectiveness with lead time requirements, especially for large-scale or urgent procurement needs.

Regulatory Considerations

Global procurement of aminosalicylic acid sodium APIs necessitates adherence to international regulations. APIs must conform to pharmacopoeial standards and possess appropriate documentation, such as Certificates of Analysis (CoA), Certificates of Suitability (CoS), and Drug Master Files (DMFs), where applicable. Harmonization of standards through ICH guidelines simplifies cross-region compliance.

Emerging Trends and Considerations

• Quality Assurance Acceleration: Suppliers are increasingly adopting advanced analytical techniques (e.g., HPLC, GC-MS) for process validation.
• Environmental Sustainability: Emphasis on green manufacturing practices aligns with global regulatory trends.
• Supply Chain Transparency: Blockchain and digital audits are gaining traction to ensure traceability and combat counterfeit APIs.
• Regional Expansion: Manufacturers are expanding capacities in emerging markets to meet global demand while maintaining quality standards.

Conclusion

Sourcing aminossalicylic acid sodium API involves balancing quality, regulatory compliance, reliability, and cost. Top suppliers from India, China, Europe, and the United States possess differentiated capabilities suitable for various regulatory environments and market demands. Strategic supplier selection, rigorous quality control, and compliance adherence are vital for uninterrupted supply chains and patient safety.

---

Key Takeaways

• Indian and Chinese manufacturers dominate the global supply of aminosalicylic acid sodium APIs, driven by cost and capacity advantages.
• European and U.S. suppliers often serve markets requiring stringent regulatory compliance and high purity standards.
• Selecting a supplier involves monitoring regulatory certifications, quality assurance processes, and supply chain reliability.
• Compliance with international pharmacopoeial standards (USP, BP, EP) and regulatory documentation (CoA, CoS) is essential.
• Emerging trends include the integration of digital traceability tools, sustainable manufacturing practices, and increasing regional production capacities.

---

Frequently Asked Questions

1. What are the primary regulatory standards to consider when sourcing aminosalicylic acid sodium APIs?
Regulators typically require compliance with pharmacopoeial standards such as USP, BP, or EP, alongside certifications like WHO GMP, EU GMP, or FDA approval to ensure quality and safety.

2. How can companies verify the quality of aminosalicylic acid sodium APIs from international suppliers?
Verification involves reviewing Certificates of Analysis, conducting site audits, requesting stability, impurity profiles, and ensuring the supplier's manufacturing practices adhere to internationally recognized standards.

3. What quality attributes are most critical in sourcing aminosalicylic acid sodium APIs?
High chemical purity (>99%), low levels of impurities, consistent batch-to-batch quality, and comprehensive documentation are crucial attributes.

4. Are there particular regions more reliable for sourcing aminosalicylic acid sodium?
India and China provide large-scale, cost-effective options, but European and American suppliers often prioritize regulatory compliance and rigorous quality standards, making them preferable for certain markets.

5. What future trends are anticipated in the sourcing of aminosalicylic acid sodium APIs?
Increased adoption of digital transparency tools, focus on sustainable manufacturing, expanded production capacity in emerging markets, and stricter regulatory environments will shape sourcing practices.

---

Sources:

[1] Pharmaceutical Commerce. "Global Active Pharmaceutical Ingredient Market Overview." 2022.
[2] World Health Organization. "WHO Prequalification of Medicines Programme." 2022.
[3] United States Pharmacopeia. "USP Standards for Active Pharmaceutical Ingredients." 2023.
[4] European Medicines Agency. "Guidelines on API Standards." 2022.
[5] Indian Pharmaceutical Industry Association Reports. 2022.